The Effect of Diabetes Mellitus on the Prognosis of Patients With COVID-19 (COVID-19-DM2)

Uşak University

Status: Unknown

Conditions: Diabetes Mellitus; Covid19

Treatments: Other: hospitalisation, necessity of ICU, mortality rate, lung involvement

Study type: Observational

Funder types: Other

Identifiers

NCT04591704

UU-DM003

Details and patient eligibility

About

All hospitalised patients with COVID-19 who have positive RT-PCR for SARS-COV-2 will be included in the study.

The patients will be divided into two groups, as diabetics and non-diabetics. The COVID-19 patients' medical records will be evaluated and compared in terms of the duration of hospitalization, the presence of lung involvement in Computerised Tomography, the need for intensive care unit and mortality rates in patients with and without diabetes.

Full description

All hospitalised patients with COVID-19 who have positive RT-PCR for SARS-COV-2 will be included in the study.

The patients will be divided into two groups, as diabetics and non-diabetics. The diagnosis of diabetes mellitus will be extracted from the medical records and medical history of the patients hospitalised with COVID-19.

The COVID-19 patients medical records will be evaluated and compared in terms of the duration of hospitalization, the presence of lung involvement in Computerised Tomography, the need for intensive care unit and mortality rates in patients with and without diabetes.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients hospitalized for COVID-19

Exclusion criteria

• Patients with known malignancy
• Pregnant patients

Trial design

2,000 participants in 2 patient groups

Diabetic groups

Description:

COVID-19 patients with diabetes mellitus

Treatment:

Other: hospitalisation, necessity of ICU, mortality rate, lung involvement

Control groups

Description:

COVID-19 patients without diabetes mellitus

Treatment:

Other: hospitalisation, necessity of ICU, mortality rate, lung involvement